Insider trades
Curran Simpson, CEO of Regenxbio RGNX, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $262.6K. The latest trade was on 01/06.
Curran Simpson
CEO
- Company
- Regenxbio RGNX
- First filing
- 23/01/05
- Trades
- 21 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$262.6K
- Last trade
- 01/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RegenxbioRGNX | Open-market sale10b5-1 plan | 25/10/09 | 25/10/10 | 20,811 sh | $12.62 | $262,634.82 | −8.8% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 25/09/29 | 25/10/01 | 7,624 sh | $10.03 | $76,468.72 | −3.1% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 25/09/10 | 25/09/12 | 7,734 sh | $10.02 | $77,494.68 | −3.1% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/08/01 | 24/08/05 | 100 sh | $15.00 | $1,500 | −0.1% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/07/29 | 24/07/30 | 9,648 sh | $15.04 | $145,105.92 | −5.4% |